Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia

KORKMAZ EKREN, PERVİN; Toreyin, Zehra; Berk Takir, Huriye; Kalamanoglu Balci, Merih; GAYGISIZ, ÜMMÜGÜLSÜM; GÜRSEL, GÜL; ERGAN, BEGÜM; Yalcin, Aslihan; Salturk, Cuneyt; AYDOĞDU, MÜGE; Ergun, Recai; Guven, Pinar; Ulubay, Gaye; Gurun Kaya, Aslihan; ÇELTİK, AYGÜL; ULUER, HATİCE; Bacakoglu, Feza; SAYINER, ABDULLAH

doi:10.5578/tt.59748

Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia

KORKMAZ EKREN P., Toreyin Z. N., Berk Takir H., Kalamanoglu Balci M., GAYGISIZ Ü., GÜRSEL G., ...More

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.65, no.4, pp.271-281, 2017 (ESCI, Scopus, TRDizin)

Publication Type: Article / Article
Volume: 65 Issue: 4
Publication Date: 2017
Doi Number: 10.5578/tt.59748
Journal Name: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Page Numbers: pp.271-281
Keywords: Nosocomial infection, pneumonia, multidrug resistant, colistimethate sodium, toxicity
Dokuz Eylül University Affiliated: Yes

Abstract

Introduction: Colistimethate sodium (CMS) is frequently used in the treatment of nosocomial multidrug-resistant gram-negative infections. Nephrotoxicity is the most important side effect. The aim of this study is to evaluate the effect of colistin on nephrotoxicity and to assess prognosis in patients treated with CMS due to hospital-acquired pneumonia (HAP).